A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
Clinical trial NCT07107932 · RECRUITING
Trial details
- NCT number
- NCT07107932
- Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-31
- Primary completion
- 2029-03-30
- Enrollment
- 10000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.